Trial NCT04369742
Publication Ulrich RJ, Open Forum Infect Di, 2020
Primary outcome on the report: Proportion of subjects meeting a severe COVID-19 progression composite endpoint (death, ICU admission, mechanical ventilation, ECMO, and/or vasopressor use) at day 14; Cumulative incidence of SAE, grade 3 or 4 AE, and/or discontinuation of therapy at day 30.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.